Concepedia

Hans Lanz

HL

25

Publications

1.8K

Citations

19

H-Index

1988

Active since

Affiliations

Daiichi Sankyo (United States)(Current)

Thrombolysis in Myocardial Infarction Study Group

Brigham and Women's Hospital

Daiichi Sankyo (Germany)

Harvard University

Hans Lanz is an author at Daiichi Sankyo (United States) specializing in medicine, pharmacotherapy, and thrombosis.

Top concepts

Publications per year

1988–2023

25

Publications

25

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

Eri Kato, Robert P. Giugliano, Christian T. Ruff et al. · Journal of the American Heart Association · 2016 · 275 citations · Full text

Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate

Hamim Zahir, Karen Brown, Alexander G. Vandell et al. · Circulation · 2014 · 250 citations

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation

Mark S. Link, Robert P. Giugliano, Christian T. Ruff et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 180 citations

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Gary E. Raskob, Nick van Es, Annelise Segers et al. · The Lancet Haematology · 2016 · 154 citations

, , +8

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Jack Ansell, Sasha Bakhru, Bryan Laulicht et al. · Thrombosis and Haemostasis · 2016 · 146 citations · Full text

, , +12

Rows per page

1–5 of 25